High Risk: The Debate Over the Price of Specialty Drugs and Zika Virus
In an interview with CFIF, Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses the history and regulations surrounding drug prices, who should finance important medical advancements, and the continuing Zika threat.
Leveraging federal authorities like the Internal Revenue Service (IRS) to persecute political opponents stands among the most grave abuses that officials can commit, as Richard Nixon learned the hard way four decades ago.
This month, an Obama Administration and IRS attempt to evade legal reckoning for their own admitted abuses suffered a stinging judicial setback.
Not only did the nation's second-highest court reject the administration's argument that dozens of lawsuits filed by conservative and libertarian groups against the IRS should be dismissed, the unanimous three-judge panel…
"The first Clinton-Trump debate was roughly a draw -- which is bad news for her, because she needs to turn this race around, and she failed. ...Donald Trump remains the candidate of change; Hillary Clinton, the tribune of the status quo."…[more]